This drug maker, 40% owned by MF & FPIs, just had a weak Q2. Time to sell?
NEW DELHI: Shares of Ipca Laboratories have fallen after the drug maker's disappointing September quarter results.
Analysts said they expect a couple of “quiet quarters” ahead, and have…